{"id":"W4318539067","doi":"10.1093/ecco-jcc/jjac190.0791","title":"P661 Clinical response over 24 weeks for initial and delayed responders to induction therapy with risankizumab in Crohn’s disease: data from the ADVANCE and MOTIVATE studies","year":2023,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Crohn's disease; Placebo; Clinical trial; Internal medicine; Post-hoc analysis; Gastroenterology; Induction therapy; Abdominal pain; Maintenance therapy; Surgery; Disease; Chemotherapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01103839,0.0007974898,0.002313187,0.0007602409,0.0003072503,0.0008793213,0.0005577958,0.001106255,0.001890735],"category_scores_gemma":[0.007260364,0.0004126508,0.003495746,0.0007282686,0.0006279779,0.0007796598,0.0006748504,0.00139195,0.0003132507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003570464,"about_ca_system_score_gemma":0.0006373986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003611569,"about_ca_topic_score_gemma":0.0008237879,"domain_scores_codex":[0.9939976,0.00341017,0.0007844236,0.0005776237,0.0009839974,0.0002461796],"domain_scores_gemma":[0.9873191,0.005220676,0.004560536,0.001218606,0.0008759933,0.0008050668],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8164467,0.003660894,0.07987422,0.003409354,0.01713773,0.0001683619,0.0003114552,0.0008422617,0.008650852,0.0001400594,0.001647389,0.06771082],"study_design_scores_gemma":[0.1494807,0.2510831,0.5574427,0.0005928069,0.023144,0.000881618,0.0002610767,0.001443767,0.006697431,0.000289341,0.008493207,0.0001901759],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9774992,0.01748959,0.0006089002,0.0001519103,0.00005966306,0.0004900667,0.002075125,0.00002905692,0.001596372],"genre_scores_gemma":[0.9941108,0.002512965,0.000430424,0.0001723228,0.000196239,0.00026462,0.001911629,0.00001101977,0.0003900498],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01103839,"threshold_uncertainty_score":0.05837733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05915514930972577,"score_gpt":0.3737190047469444,"score_spread":0.3145638554372186,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}